The UK Medicines and Healthcare products Regulatory Agency (MHRA) has made updated safety and educational materials available. These resources are intended to help implement the regulatory measures outlined in the November 2023 National Patient Safety Alert and the September 2024 Drug Safety Update.
The new materials aim to support healthcare professionals in discussing relevant risks with patients, ensuring compliance with the latest safety guidance.
Cập nhật pháp chế24 thg 8, 2026•1 phút đọc
MHRA Publishes Updated Safety and Educational Materials
MHRA releases new safety and educational resources to support regulatory measures from the 2023 Patient Safety Alert and 2024 Drug Safety Update.
Tổng hợp bởi đội ngũ PharmaCountry · Nguồn: MHRA
Đánh giá
(0)
(0)
(0)
(0)
(0)
Bài viết khác
Xem tất cả bài viếtNghiên cứu & Báo cáo
Global Finished Dosage Manufacturing Landscape 2026
5 thg 10, 2026
Cập nhật pháp chếKorea Korus hit with 1‑month manufacturing suspension over missing post‑marketing safety test
28 thg 9, 2026
Phân tíchPharma distributors set delivery cut‑offs ahead of Chuseok holiday (Sep 21‑23)
28 thg 9, 2026
Để lại đánh giá